SANUWAVE Health, Inc. Common Stock earnings per share and revenue
On Mar 19, 2026, SNWV reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of 0.17 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 13.52 million, with a --% difference.
Looking ahead to Q1 26, 3 analysts forecast an EPS of 0.08 USD, with revenue projected to reach 11.32 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were SANUWAVE Health, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, SANUWAVE Health, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to SANUWAVE Health, Inc. Common Stock's Q4 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is SANUWAVE Health, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 07, 2026.
What are the forecasts for SANUWAVE Health, Inc. Common Stock's next earnings report?
Based on 3
analysts, SANUWAVE Health, Inc. Common Stock is expected to report EPS of $0.08 and revenue of $11.32M for Q1 2026.